Stephen A. Sherwin, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 40,000 shares at $133.47 ($5.3M) on 2024-05-29, disclosed to the SEC on 2024-05-30.
Scheduled sale ($5.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.46 | 25,000 | $3.3M | 62.5% |
| 2 | $133.47 | 15,000 | $2.0M | 37.5% |
| Total | $133.46 avg | 40,000 | $5.3M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $3.2M | — | Filing → |
| NBIX | SELL | 2023-01-05 | $3.6M | — | Filing → |
| NBIX | SELL | 2022-01-26 | $1.1M | — | Filing → |